We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The board of directors at Gilead Sciences has announced it has chosen Daniel O’Day, the current CEO of Roche Pharmaceuticals and member of the Roche Group’s corporate executive committee.....